Exploring the intriguing interplay between ketamine and Rapamycin, the discussion highlights the goal of creating an optimized environment for brain health. By minimizing drug exposure while maximizing treatment benefits, there's potential for longer-lasting effects and improved accessibility for patients. This approach not only reduces risks but also enhances treatment adherence and affordability.
